Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Can Bitcoin Maintain the Latest Rally? Experts Express Mixed Reactions
-
VanEck CEO: Get Ready for a ‘Thrilling’ Ride as Gold and Bitcoin Enter Bullish Cycles
-
Cryptos Rise; Bitcoin Touches 3-week High
-
Bears Drag Bitcoin to Lowest Price Level In Two Years — Where’s BTC Headed Next?
-
Amidst Hawkish Fed Hints, Markets Wary Of Jobs Data
